The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ghanshyam Jaju
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ghanshyam Jaju, a promoter of Godavari Drugs Ltd, acquired 1,80,000 convertible warrants through a preferential allotment on 18th March 2026, valued at Rs. 7,53,06,000. Before the acquisition, he held 3,50,000 equity shares (4.65% voting rights). After the allotment, his total holding — shares plus warrants — stands at 5,30,000, representing 3.46% of current voting capital and 4.24% on a fully diluted basis (assuming full conversion of warrants). The filing was made under SEBI's SAST Regulation 29(2) for disclosure of the acquisition, and a related disclosure was also filed under SEBI's Insider Trading Regulation 6(2).
This is a promoter-led increase in stake, generally seen as a confidence signal from the promoter. However, the post-allotment voting stake is modest (3.46%), and the warrants are not yet shares, so any meaningful boost to promoter control will depend on future conversion.